https://www.labiotech.eu/trends-news/brainever-3p-biopharmaceuticals-developing-drug-hopes-cure-als/
3P and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat ALS or Parkinson’s disease.
Create an account or login to join the discussion